Encompass Health’s Cash Flow Strength Offsets Slower Same-Store Growth
StockStory cited strong cash flow and returns on invested capital, while noting that same-store sales growth trailed the sector.
Key takeaways
- Encompass Health’s trailing-12-month free cash flow margin was 12.6%.
- Its same-store sales averaged 4% annual growth over the last two years, slightly below the sector.
StockStory said Encompass Health’s strengths outweigh its challenges, citing its cash flow and returns on invested capital. The publisher reported that the company’s shares had risen 15.7% over six months, compared with a 13.5% gain for the S&P 500.
Encompass Health’s free cash flow margin expanded by 3.4 percentage points over five years, reaching 12.6% for the trailing 12 months. Its five-year average return on invested capital was 15.8%, according to StockStory.
The publisher also noted that same-store sales averaged 4% annual growth over the past two years, slightly behind the sector. As of 15:04 UTC, EHC traded at $124.33, down 0.07% since the previous close.
This article was produced with the help of AI technology. Source: Yahoo Finance
